In vitro transdifferentiation of hepatoma cells into functional pancreatic cells

W C Li, M E Horb, D Tosh, J M W Slack

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

We have characterised the transdifferentiation of human HepG2 (hepatoma) cells to pancreatic cells following introduction of an activated version of the pancreatic transcription factor Pdx1 (XlHbox8-VP16). The following questions are addressed: (1) are all types of pancreatic cells produced? (2) is the requirement for expression of the transgene temporary or permanent? (3) are the transdifferentiated beta-cells responsive to physiological stimuli? The results showed that both pancreatic exocrine cells (by detection of amylase protein), and endocrine cells (by detecting insulin, glucagon and somatostatin proteins) are induced after XIHbox8VP16 transfection. Moreover, the hepatic phenotype becomes suppressed during transdifferentiation of hepatocytes to pancreatic cells. Requirement for the transgene is only temporary and it is no longer required once the pancreatic differentiation program is activated. Finally, we provided results to suggest that the transdifferentiated cells are functional by detecting: (1) functional markers for pancreatic beta-cells including prohormone convertase 1/3 (PC 1/3), insulin C-peptide and glucagon-like peptide I receptor (GLP-IR), (2) increased insulin mRNA expression after treatment of cells with GLP-1 and betacellulin, physiological stimuli that regulate pancreatic function and (3) elevated insulin secretion after glucose challenge. The transdifferentiation of hepatic to pancreatic cells represents one possible source of P-cells for human islet transplantation and this study shows that such a transdifferentiation can be achieved in vitro.
Original languageEnglish
Pages (from-to)835-847
Number of pages13
JournalMechanisms of Development
Volume122
Issue number6
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Cell Transdifferentiation
Hepatocellular Carcinoma
Proprotein Convertase 1
Insulin
Glucagon
Transgenes
In Vitro Techniques
Islets of Langerhans Transplantation
Glucagon-Like Peptide 1
Endocrine Cells
C-Peptide
Liver
Hep G2 Cells
Insulin-Secreting Cells
Amylases
Somatostatin
Transfection
Hepatocytes
Proteins
Transcription Factors

Cite this

In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. / Li, W C; Horb, M E; Tosh, D; Slack, J M W.

In: Mechanisms of Development, Vol. 122, No. 6, 06.2005, p. 835-847.

Research output: Contribution to journalArticle

@article{913fdb4f01ab4abbab4906f094df4604,
title = "In vitro transdifferentiation of hepatoma cells into functional pancreatic cells",
abstract = "We have characterised the transdifferentiation of human HepG2 (hepatoma) cells to pancreatic cells following introduction of an activated version of the pancreatic transcription factor Pdx1 (XlHbox8-VP16). The following questions are addressed: (1) are all types of pancreatic cells produced? (2) is the requirement for expression of the transgene temporary or permanent? (3) are the transdifferentiated beta-cells responsive to physiological stimuli? The results showed that both pancreatic exocrine cells (by detection of amylase protein), and endocrine cells (by detecting insulin, glucagon and somatostatin proteins) are induced after XIHbox8VP16 transfection. Moreover, the hepatic phenotype becomes suppressed during transdifferentiation of hepatocytes to pancreatic cells. Requirement for the transgene is only temporary and it is no longer required once the pancreatic differentiation program is activated. Finally, we provided results to suggest that the transdifferentiated cells are functional by detecting: (1) functional markers for pancreatic beta-cells including prohormone convertase 1/3 (PC 1/3), insulin C-peptide and glucagon-like peptide I receptor (GLP-IR), (2) increased insulin mRNA expression after treatment of cells with GLP-1 and betacellulin, physiological stimuli that regulate pancreatic function and (3) elevated insulin secretion after glucose challenge. The transdifferentiation of hepatic to pancreatic cells represents one possible source of P-cells for human islet transplantation and this study shows that such a transdifferentiation can be achieved in vitro.",
author = "Li, {W C} and Horb, {M E} and D Tosh and Slack, {J M W}",
year = "2005",
month = "6",
doi = "10.1016/j.mod.2005.01.001",
language = "English",
volume = "122",
pages = "835--847",
journal = "Mechanisms of Development",
issn = "0925-4773",
publisher = "Elsevier Ireland Ltd",
number = "6",

}

TY - JOUR

T1 - In vitro transdifferentiation of hepatoma cells into functional pancreatic cells

AU - Li, W C

AU - Horb, M E

AU - Tosh, D

AU - Slack, J M W

PY - 2005/6

Y1 - 2005/6

N2 - We have characterised the transdifferentiation of human HepG2 (hepatoma) cells to pancreatic cells following introduction of an activated version of the pancreatic transcription factor Pdx1 (XlHbox8-VP16). The following questions are addressed: (1) are all types of pancreatic cells produced? (2) is the requirement for expression of the transgene temporary or permanent? (3) are the transdifferentiated beta-cells responsive to physiological stimuli? The results showed that both pancreatic exocrine cells (by detection of amylase protein), and endocrine cells (by detecting insulin, glucagon and somatostatin proteins) are induced after XIHbox8VP16 transfection. Moreover, the hepatic phenotype becomes suppressed during transdifferentiation of hepatocytes to pancreatic cells. Requirement for the transgene is only temporary and it is no longer required once the pancreatic differentiation program is activated. Finally, we provided results to suggest that the transdifferentiated cells are functional by detecting: (1) functional markers for pancreatic beta-cells including prohormone convertase 1/3 (PC 1/3), insulin C-peptide and glucagon-like peptide I receptor (GLP-IR), (2) increased insulin mRNA expression after treatment of cells with GLP-1 and betacellulin, physiological stimuli that regulate pancreatic function and (3) elevated insulin secretion after glucose challenge. The transdifferentiation of hepatic to pancreatic cells represents one possible source of P-cells for human islet transplantation and this study shows that such a transdifferentiation can be achieved in vitro.

AB - We have characterised the transdifferentiation of human HepG2 (hepatoma) cells to pancreatic cells following introduction of an activated version of the pancreatic transcription factor Pdx1 (XlHbox8-VP16). The following questions are addressed: (1) are all types of pancreatic cells produced? (2) is the requirement for expression of the transgene temporary or permanent? (3) are the transdifferentiated beta-cells responsive to physiological stimuli? The results showed that both pancreatic exocrine cells (by detection of amylase protein), and endocrine cells (by detecting insulin, glucagon and somatostatin proteins) are induced after XIHbox8VP16 transfection. Moreover, the hepatic phenotype becomes suppressed during transdifferentiation of hepatocytes to pancreatic cells. Requirement for the transgene is only temporary and it is no longer required once the pancreatic differentiation program is activated. Finally, we provided results to suggest that the transdifferentiated cells are functional by detecting: (1) functional markers for pancreatic beta-cells including prohormone convertase 1/3 (PC 1/3), insulin C-peptide and glucagon-like peptide I receptor (GLP-IR), (2) increased insulin mRNA expression after treatment of cells with GLP-1 and betacellulin, physiological stimuli that regulate pancreatic function and (3) elevated insulin secretion after glucose challenge. The transdifferentiation of hepatic to pancreatic cells represents one possible source of P-cells for human islet transplantation and this study shows that such a transdifferentiation can be achieved in vitro.

UR - http://dx.doi.org/10.1016/j.mod.2005.01.001

U2 - 10.1016/j.mod.2005.01.001

DO - 10.1016/j.mod.2005.01.001

M3 - Article

VL - 122

SP - 835

EP - 847

JO - Mechanisms of Development

JF - Mechanisms of Development

SN - 0925-4773

IS - 6

ER -